A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions

Authors:: Anil Pawar; Maria Russo; Isha Rani; Kalyan Goswami; Gian Luigi Russo; Amit Pal

Reference:: Phytotherapy Research; 2022; 36; 2394-2415

DOI:: 10.1002/ptr.7461

See Abstract

Key Words:: Review article; COVID-19; quercetin; clinical study

Back to index